News

Tandem Diabetes Care achieves record Q1 2025 sales with 22% growth, launches Control-IQ+ for type 2 diabetes, doubling its market potential.
Diabetes insipidus affects the kidneys but does not concern blood sugar control like diabetes mellitus. Learn about the ...
Novo Nordisk A/S faces challenges in the obesity market, but new trials and innovations offer hope. Read more on NVO stock ...
Advances in type 1 diabetes technology give people with the condition and their caregivers a little more freedom in their daily lives, helping reduce the constant worry about blood glucose levels or ...
Robert F. Kennedy, Jr., declared chronic diseases an “existential threat.” Then his agency terminated one of the world’s ...
An AI-powered system requires training about how to interpret and make sense of the data that it’s trained on, and users must know how to craft their questions to solicit ... year-old male diagnosed ...
This way, you can take action before the problem turns into a medical emergency. ‌If you have diabetes, your body has trouble processing the food you eat and turning it into energy. This means ...
Gymnema is a complementary treatment for type 1 and type 2 diabetes. While it isn’t a replacement for insulin, it may aid in blood sugar regulation. Gymnema is a woody climbing shrub from the ...
WASHINGTON: A new American study has shown that diabetes during pregnancy is associated with an increased risk of brain and nervous system problems in children, particularly autism. The study, ...
Diabetes is known to cause many medical issues, from heart disease to vision problems — and now a new study suggests it could also impact memory and other cognitive functions. After observing ...
Two significant programs that invested in research on diabetes, dementia, obesity and kidney disease have ended since the start of the Trump administration. By Gina Kolata Robert F. Kennedy Jr ...